Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.
Hum Resour Health. 2024 May 27;22(1):32. doi: 10.1186/s12960-024-00913-0.
Eswatini faces persistent challenges in providing care for diabetes and hypertension, exacerbated by a shortage of healthcare workers. The implementation of WHO-PEN interventions aimed to address these issues, yet their effects on healthcare worker time requirements and associated costs remain unclear.
This study employed a time-and-motion analysis and a bottom-up cost assessment to quantify the human and financial resources required for scaling up WHO-PEN interventions nationally in Eswatini for all estimated diabetic and hypertensive patients.
Findings reveal that healthcare workers in intervention-arm clinics reported longer workday durations compared to those in control-arm clinics, yet spent less time per patient while seeing more patients. The implementation of WHO-PEN interventions increased the workload on healthcare workers but also led to a notable increase in patient care utilization. Furthermore, a morning peak in patient visits was identified, suggesting potential opportunities for optimizing patient flow. Notably, scaling up care provision nationally with WHO-PEN interventions proved to be more cost saving than expanding standard-of-care treatment.
WHO-PEN interventions hold promise in improving access to diabetes and hypertension care in Eswatini while offering an efficient solution. However, addressing challenges in healthcare workforce creation and retention is crucial for sustained effectiveness. Policy makers must consider all aspects of the WHO-PEN intervention for informed decision-making. Trial registration US Clinical Trials Registry. NCT04183413. Trial registration date: December 3, 2019. https://ichgcp.net/clinical-trials-registry/NCT04183413.
斯威士兰在提供糖尿病和高血压护理方面面临持续挑战,医护人员短缺问题使情况恶化。实施世卫组织 PEN 干预措施旨在解决这些问题,但这些干预措施对医护人员时间需求和相关成本的影响尚不清楚。
本研究采用时间和运动分析以及自下而上的成本评估,量化了在斯威士兰全国范围内扩大世卫组织 PEN 干预措施所需的人力和财力资源,以覆盖所有估计的糖尿病和高血压患者。
研究结果表明,干预组诊所的医护人员报告的工作日时长长于对照组诊所,但每位患者的治疗时间更少,而看诊的患者更多。实施世卫组织 PEN 干预措施增加了医护人员的工作量,但也显著增加了患者护理的利用率。此外,还发现患者就诊存在上午高峰,这表明优化患者流量存在潜在机会。值得注意的是,全国范围内扩大世卫组织 PEN 干预措施提供护理服务的成本比扩大标准护理治疗更具成本效益。
世卫组织 PEN 干预措施有望改善斯威士兰的糖尿病和高血压护理服务获取,同时提供高效的解决方案。然而,解决医护人员队伍建设和留用方面的挑战至关重要,以确保持续有效。决策者必须考虑世卫组织 PEN 干预措施的所有方面,以便做出明智的决策。试验注册:美国临床试验注册处。NCT04183413。试验注册日期:2019 年 12 月 3 日。https://ichgcp.net/clinical-trials-registry/NCT04183413。